Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $18.2700 (0.61%) ($18.0900 - $18.6800) on Sat. Oct. 12, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.9% (three month average) | RSI | 39 | Latest Price | $18.2700(0.61%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -1.1% a day on average for past five trading days. | Weekly Trend | IOVA declines -1.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting IOVA price | IOVA will decline at least -1.45% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.45% (StdDev 2.9%) | Hourly BBV | 0 () | Intraday Trend | -0.1% | | | |
|
1 - 5 Day Possible Target | $7.13(-60.97%) | Resistance Level | $19.31 | 5 Day Moving Average | $18.54(-1.46%) | 10 Day Moving Average | $18.73(-2.46%) | 20 Day Moving Average | $19.31(-5.39%) | To recent high | -29.7% | To recent low | 1.6% | Market Cap | $N/A | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |